Investor insights
Sectors invested in
Funding rounds participated in
$93M sweet spot round size
Most of their 30 investments are in rounds between $62M and $115M
Investor type
Basic info
Industry
Sectors
Date founded
2008
Investments made
Beta Bionics raised $100M on August 30, 2023
Investors: Sands Capital Management, Farallon Capital Management, Pura Vida Investments, Perceptive Advisors, Marshall Wace, RTW Investments, LP, Soleus Capital Management, L.P., LifeSci Venture Partners, Omega Funds and Eventide Asset Management
Flare Therapeutics raised $123M on March 22, 2023
Investors: ShangBay Capital, Nextech Invest, The Invus Group, GordonMD Global Investments LP, Third Rock Ventures and Eventide Asset Management
VectivBio AG raised $125M on October 13, 2022
Investors: TCG X, Surveyor Capital, OrbiMed Advisors, Marshall Wace, Vivo Capital, Driehaus Capital Management LLC, Forbion and Eventide Asset Management
Beta Bionics raised $57M on February 17, 2022
Investors: Soleus Capital Management, L.P., Pura Vida Investments, Novo Nordisk Ltd, LifeSci Venture Partners, RTW Investments, LP, Farallon Capital Management, Perceptive Advisors and Eventide Asset Management
Shoreline Biosciences, Inc. raised $140M on November 2, 2021
Investors: NS Investment, Kingdon Capital Management, Wedbush Securities, Irving Investors, Stork Capital S.à.r.l., -, Piper Sandler and Eventide Asset Management
Roivant Sciences raised $200M on October 1, 2021
Investors: Suvretta Capital Management LLC, Patient Square Capital, Dainippon Sumitomo Pharma, Palantir Technologies, Viking Global Investors, RTW Investments, LP and Eventide Asset Management
DiCE Molecules raised $60M on August 24, 2021
Investors: New Leaf Venture Partners, Soleus Capital Management, L.P., Northpond Ventures, Logos Global Management, LP, Sands Capital Management, Driehaus Capital Management LLC, Osage University Partners (OUP), RA Capital Management, L.P. and Eventide Asset Management
Kojin Therapeutics raised $60M on June 9, 2021
Investors: Newpath Partners, Leaps by Bayer, Cathay Capital, Polaris Partners and Eventide Asset Management
Flare Therapeutics raised $82M on May 13, 2021
Investors: The Invus Group, Third Rock Ventures, Nextech Invest, Casdin Capital, LLC and Eventide Asset Management
Arch Oncology raised $105M on April 27, 2021
Investors: RiverVest Venture Partners, Avego Healthcare Capital, Adage Capital Management, Point72 Asset Management and Eventide Asset Management